Investing in cancer research has the potential to yield substantial returns. For example, breakthroughs in cancer treatments can lead to longer, healthier lives for patients and reduced healthcare costs over time. Moreover, advancements in early detection and prevention can significantly reduce the burden on healthcare systems and improve quality of life. Hence, understanding the ROI helps in making informed decisions about funding allocation and policy-making.
